JPRN-UMIN000002385
Completed
Phase 2
A phase II, multicenter, study for newly diagnosed glioblastomas using boron neutron capture therapy, additional X-ray treatment and chemotherapy - BNCT, XRT plus chemotherapy for newly diagnosed GBM
Dept. of Neurosurgery, Osaka Medical College0 sites45 target enrollmentSeptember 1, 2009
Conditionsewly-diagnosed glioblastoma
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- ewly-diagnosed glioblastoma
- Sponsor
- Dept. of Neurosurgery, Osaka Medical College
- Enrollment
- 45
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients who have been treated with chemotherapy or radiotherapy. 2\) Female patients in definitive or possible pregnancy or in breast\-feeding. 3\) Patients with phenylketonuria. 4\) Patients with grade III or IV in NYHA classification. 5\) Patients with cerebrospinal fluid dissemination. 6\) Other patients whose participation in the present study is considered inappropriate by a Principal Investigator or Clinical Investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
A phase II, multicentre, clinical study evaluating the safety and efficacy of Treosulfan-based conditioning of allogenic transplantation of haemopoietic stem-cells in patients affected by Thalassemia Major - NDEUCTR2005-005913-40-ITOSPEDALE POLICLINICO S. MATTEO10
Active, not recruiting
Not Applicable
A multicentre phase I-II study to investigate the combination of bendamustine with weekly paclitaxel as first or second line therapy in patients with metastatic breast cancer - RitaEUCTR2004-004880-31-DEGerman Breast Group Forschungs GmbH60
Unknown
Phase 2
A phase 2 multicenter clinical study evaluating the safety and efficacy of Nilotinib in patients with Imatinib- resistant/intolerant CML in chronic phaseChronic myelogenous leukemiaJPRN-UMIN000001927Tokyo STI Study Group50
Not yet recruiting
Phase 2
Gene Xpert XDR-TB Kit EvaluatioHealth Condition 1: J708- Respiratory conditions due to other specified external agentsCTRI/2019/07/020139Foundation for Innovative New Diagnostics India
Active, not recruiting
Phase 2
A Phase II, Multi-Center, Investigator-Initiated Study of Dasatinib against AITL and Other T Follicular Helper Cell LymphomaRelapsed/refractory T Follicular Helper Cell LymphomaJPRN-jRCT2031190079Chiba Shigeru18